GSK Investigational Site

Lévis, Quebec G6V 4Z5

0 studies enrolling now · 8 studies all time

What they study most

Atherosclerosis, Bowel Dysfunction, Constipation, Crohn's Disease, Diabetes Mellitus, Lung Cancer, Non-Small Cell, Nausea, Nausea and Vomiting, Chemotherapy-Induced, Non-Small-Cell Lung Cancer, Vomiting

Studies at this site

• Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer — Completed
• Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus — Completed
• A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease — Completed
• Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication — Completed
• The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial — Completed
• A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer — Stopped early
• Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease — Completed
• Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting — Completed